| 000 | 01841 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513153321.0 | ||
| 264 | 0 | _c19990107 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0028-3908 | ||
| 024 | 7 |
_a10.1016/s0028-3908(98)00077-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriebel, G | |
| 245 | 0 | 0 |
_aBehavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cJul 1998 |
||
| 300 |
_a927-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiogenic Monoamines _xmetabolism |
| 650 | 0 | 4 | _aBites and Stings |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 |
_aEscape Reaction _xdrug effects |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xmetabolism |
| 650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aPanic Disorder _xdrug therapy |
| 650 | 0 | 4 |
_aPhenelzine _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 | _aVocalization, Animal |
| 700 | 1 | _aCuret, O | |
| 700 | 1 | _aPerrault, G | |
| 700 | 1 | _aSanger, D J | |
| 773 | 0 |
_tNeuropharmacology _gvol. 37 _gno. 7 _gp. 927-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0028-3908(98)00077-x _zAvailable from publisher's website |
| 999 |
_c9741078 _d9741078 |
||